Skip to main content
Clinical Trials/ACTRN12614000361606
ACTRN12614000361606
Completed
未知

Response of Patients with COPD to Hyperoxia and Normoxia, as Measured by Carbon Dioxide Levels.

Medical Research Institute of New Zealand0 sites24 target enrollmentApril 7, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
COPD
Sponsor
Medical Research Institute of New Zealand
Enrollment
24
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 7, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • COPD, as diagnosed by a doctor.

Exclusion Criteria

  • 1\. Baseline transcutaneous carbon dioxide of greater than or equal to 60mmHg
  • 2\. FEV1:FVC ratio \>0\.7
  • 3\. Age under 16 years
  • 4\. A diagnosis of bronchiectasis
  • 5\. Morbid obesity (with a body mass index of greater than or equal to 40\)
  • 6\. Inability to match FEV1 percentage predicted to a participant that took part in the bronchiectasis oxygen study\*
  • 7\. Any other condition which, at the investigator’s discretion, is believed may present a safety risk or impact the feasibility of the study or the study results.
  • \*This study is designed to allow for comparison of results to a study of similar design in patients with bronchiectasis (ACTRN12612000356864\). Participants will therefore be matched by FEV1 to the participants in the bronchiectasis study (the COPD participant must have an FEV1 percentage predicted within an absolute value of 5% of the FEV1 percentage predicted for the bronchiectasis patient (values inclusive)).

Outcomes

Primary Outcomes

Not specified

Similar Trials